do glp-1 agonists have cardiovascular benefit Glucagon-like peptide 1 receptor agonists: benefits and mechanisms of action Cardiovascular Protection with a Long-Acting
Description
The absence of pediatric-specific clinical trials precludes definitive conclusions regarding its safety, efficacy, and tolerability in adolescents
It should be mentioned, nevertheless, that when taken with insulin, it can cause hypoglycemia [266]
You can also contact your Blue Cross and Blue Shield of Kansas representative.
Cardiovascular risk assessment in the development of new drugs for obesity
Urva, T
Nakashima S, Matsui T, Takeuchi M, Yamagishi S-I
